IMAB – i-mab - american depositary shares (US:NASDAQ)
Stock Stats
News
10/29
11:05 pm
imab
Neutral
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
10/29
11:15 am
imab
Low
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform
10/28
10:00 am
imab
Low
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of I-Mab - IMAB
10/27
10:07 am
imab
Medium
I-Mab (NASDAQ:IMAB) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
10/27
10:07 am
imab
Medium
I-Mab (NASDAQ:IMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/27
10:07 am
Reiterates
Buy
Buy
Citigroup Inc.
Medium
3.8%
10/27
10:07 am
Reiterates
Buy
Buy
HC Wainwright
Medium
3.8%
10/27
08:06 am
Reiterates
Buy
Buy
Needham & Company LLC
Low
1.5%
10/24
08:06 am
Reiterates
Buy
Buy
BTIG Research
Medium
-6.4%
10/24
05:41 am
Reiterates
Buy
Buy
BTIG
Medium
-4.1%
10/31
06:07 am
imab
Neutral
Form 6-K NovaBridge Biosciences For: Oct 31
10/30
06:04 am
imab
Neutral
Form 6-K NovaBridge Biosciences For: Oct 29
10/30
06:00 am
imab
Neutral
Form 424B3 NovaBridge Biosciences
10/29
04:05 pm
imab
Low
Form 6-K NovaBridge Biosciences For: Oct 29
10/28
04:01 pm
imab
Low
Form 6-K I-Mab For: Oct 28
Show more
Top News Gainers
2/25 I-Mab Announces Upcoming Participation at March Conferences 15.1%
4/29 Form 20-F I-Mab For: Dec 31 14.5%
3/27 Form 6-K I-Mab For: Mar 27 8.2%
4/2 I-Mab Announces First Patient Dosed in Phase 1/2a Clinical Trial of Anti-CD47 Antibody, TJC4, in China 7.5%
3/13 I-Mab Biopharma Announces Development of TJM2 to Treat Cytokine Release Syndrome Associated with Severe and Critically-Ill Patients with Coronavirus Disease (COVID-19) 7.2%
3/30 Form 6-K I-Mab For: Mar 30 4.0%
4/17 Form 6-K I-Mab For: Apr 17 3.9%
4/15 I-Mab (IMAB) Investor Presentation - Slideshow [Seeking Alpha] 3.3%
2/10 I-Mab Announces Partial Exercise of Over-Allotment Option in Initial Public Offering 1.6%
4/24 I-Mab Announces Upcoming Participation at May Conferences 0.9%
Top News Decliners
3/13 Form 6-K I-Mab For: Mar 13 -15.9%
1/17 I-MAB Announces Pricing of U.S. Initial Public Offering -15.3%
3/30 I-Mab Submits IND Application to Initiate Study of TJM2 for Treatment of Cytokine Storm Associated with Severe COVID-19 in South Korea -7.4%
4/6 Form 6-K I-Mab For: Apr 06 -5.7%
4/6 I-Mab Announces Upcoming Participation at April Conferences -4.9%
3/11 I-Mab to Report Financial Results for Full Year 2019 and Provide Corporate Update on March 31, 2020 -3.9%
2/14 Form SEC STAFF LETTER I-Mab -3.0%
2/12 Phoenix Tree Holdings Limited (NASDAQ: IMAB) is now covered by analysts at China Renaissance Securities Ltd.. They set a "buy" rating on the stock. -1.6%
3/23 Form 6-K I-Mab For: Mar 23 -1.3%
4/28 Form 6-K I-Mab For: Apr 28 -0.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3